FINANCIAL INDICATORS
2022 was a year of further progress for Ipsen, as our successful strategy enabled us to increase momentum toward our goals. Fully focused on specialty care in our three therapeutic areas—Oncology, Rare Disease and Neuroscience—our growth platforms delivered double-digit sales growth.
Ipsen sales
Year-on-year sales
Core operating income
R&D investment
Ownership of Ipsen’s share capital (% of total capital)
